Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/2013
03/26/2013US8404684 Inhibitors of phosphatidylinositol 3-kinase
03/26/2013US8404676 Oxadiazole diaryl compounds
03/26/2013US8404300 Drug releasing coatings for medical devices
03/26/2013US8404226 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
03/26/2013US8403910 Drug releasing coatings for medical devices
03/26/2013CA2712619C Dihydropyridine calcium antagonist compounds, preparation methods and medical uses thereof
03/26/2013CA2583845C 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea as crystalline sulfate salt
03/26/2013CA2474424C Salts of valsartan
03/26/2013CA2463850C Remodeling of tissues and organs
03/26/2013CA2457925C Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
03/26/2013CA2262459C Gene involved in cadasil, method of diagnosis and therapeutic application
03/21/2013WO2013039202A1 Novel acrylic acid derivative
03/21/2013WO2013039140A1 Fused heterocyclic derivative
03/21/2013WO2013038195A2 Pharmaceutical nanoparticle compositions
03/21/2013WO2013038136A1 BI-AROMATIC AND TRI-AROMATIC COMPOUNDS AS NADPH OXIDASE 2 (Nox2) INHIBITORS
03/21/2013WO2013037914A1 Substituted 4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them
03/21/2013WO2013037905A1 Use of 3-(r)-[3-(2-methoxyphenylthio)-2-(s)-methylpropyl]amino-3,4-dihydro- 2h-1,5-benzoxathiepine for preventing and/or treating cardiotoxic effects caused by chemotherapy and/or radiation
03/21/2013WO2013037894A1 Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group
03/21/2013WO2013037889A2 Vaccine
03/21/2013WO2013037857A1 Cynara scolymus extracts for the treatment of dyslipidaemia
03/21/2013WO2013037838A1 Polymorphic form of pitavastatin calcium
03/21/2013WO2013037779A1 New dihydroquinoline-2-one derivatives
03/21/2013WO2013037736A1 Indanyl-substituted 4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them
03/21/2013WO2013037724A1 Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
03/21/2013WO2013037721A1 5-cycloalkyl- or 5-heterocyclyl-nicotinamides
03/21/2013WO2013037704A1 N-(5-cycloalkyl- or 5-heterocyclyl-)-pyridin-3-yl carboxamides
03/21/2013WO2013037415A1 Substituted 4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them
03/21/2013WO2013037390A1 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
03/21/2013WO2013037389A1 Indanyl-substituted 4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them
03/21/2013WO2013037207A1 N-(3-pyridine formoxyl)- 3,5-dimethyl-1- amantadine or its pharmaceutical salt for treating vascular dementia
03/21/2013WO2013037066A1 Ocab-based tools for screening of therapeutic agents, treating and diagnosing heart disease associated with cardiac remodeling
03/21/2013WO2013016148A3 Natriuretic peptide compositions and methods of preparation
03/21/2013WO2012153950A3 Method for preparing t-butyl 2-((4r,6s)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate
03/21/2013US20130074218 Method for optimising gene expression using synonymous codon optimisation
03/21/2013US20130072667 Use of rgm and its modulators
03/21/2013US20130072567 Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine
03/21/2013US20130072549 Methods of treating cardiomyopathy
03/21/2013US20130072517 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
03/21/2013US20130072503 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
03/21/2013US20130072493 N-[4-(1H-PYRAZOLO[3,4-b]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS
03/21/2013US20130072492 Soluble guanylate cyclase activators
03/21/2013US20130072481 mTOR SELECTIVE KINASE INHIBITORS
03/21/2013US20130072468 Substituted piperazines as cb1 antagonists
03/21/2013US20130072441 Protease Inhibitors and Preventives or Remedies for Disease
03/21/2013US20130072433 Inhibitors of beta integrin-g protein alpha subunit binding interactions
03/21/2013US20130072432 Ptd-uqcrb fusion polypeptide, and pharmaceutical composition for preventing and treating ischemic diseases, containing same
03/21/2013US20130072421 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
03/21/2013US20130071443 Glycosaminoglycans
03/21/2013US20130071438 Compositions and methods for the treatment of hyperplasia
03/21/2013US20130071435 Novel herbal formulation for the modulation of immune system of hiv infected patients and a process of preparation thereof
03/21/2013US20130071407 Methods for modulating hematopoiesis and vascular growth
03/21/2013US20130071371 Method of Producing Physiological and Therapeutic Levels of Nitric Oxide Through an Oral Delivery System
03/21/2013US20130071320 Immunotherapy of autoimmune disorders using antibodies which target b-cells
03/21/2013CA2848615A1 Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group
03/21/2013CA2848487A1 Vaccine
03/21/2013CA2846785A1 New dihydroquinoline-2-one derivatives
03/21/2013CA2846366A1 Substituted 4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them
03/21/2013CA2845708A1 Cynara scolymus extracts for the treatment of dyslipidaemia
03/21/2013CA2845673A1 Pharmaceutical nanoparticle compositions
03/21/2013CA2845473A1 Indanyl-substituted 4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them
03/21/2013CA2844835A1 N-(5-cycloalkyl- or 5-heterocyclyl-)-pyridin-3-yl carboxamides
03/21/2013CA2844834A1 5-cycloalkyl- or 5-heterocyclyl-nicotinamides
03/20/2013EP2570478A1 Reducing agent from microorganism belonging to genus bacillus and application for same
03/20/2013EP2570417A1 Thienopyridine ester derivative containing nitrile, preparation method, use and composition thereof
03/20/2013EP2570408A1 Hexaketide compound and medicinal use thereof
03/20/2013EP2570403A1 Urea compounds and use thereof for inhibiting apoptosis
03/20/2013EP2570136A2 Protein A compositions and methods of use
03/20/2013EP2570135A1 Vaccine
03/20/2013EP2569429A1 Compositions and methods for modulating metabolism
03/20/2013EP2569319A1 Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
03/20/2013EP2569310A1 Morpholine compounds as mineralocorticoid receptor antagonists
03/20/2013EP2569298A1 Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
03/20/2013EP2569019A2 Compositions, methods and systems for the synthesis and use of imaging agents
03/20/2013EP2568995A1 Therapeutic use of agonists or antagonists of bradykinin receptor 1 or 2, for modulation collateral blood vessel growth
03/20/2013EP2568982A1 Association of xanthine oxidase inhibitors and angiotensin ii receptor antagonists and use thereof
03/20/2013EP2568981A1 Association of xanthine oxidase inhibitors and statins and use thereof
03/20/2013EP2568971A1 Canagliflozin containing tablets
03/20/2013CN1822846B Perivascular mesenchymal precursor cell induced blood vessel formation
03/20/2013CN1606554B Beta-lactamyl vasopressin v1a antagonists
03/20/2013CN1541107B Growth factor complex
03/20/2013CN102985432A Derivative of AMP to treat cardiac diseases
03/20/2013CN102985420A Cytochrome P450 inhibitors and uses thereof
03/20/2013CN102985418A Apoptosis signal-regulating kinase inhibitors
03/20/2013CN102985407A 8-hydroxy-quinoline derivatives
03/20/2013CN102985075A Canagliflozin containing tablets
03/20/2013CN102985065A Use of glabranin for stimulating hair growth
03/20/2013CN102978099A Brewing method of burdock crabapple vinegar
03/20/2013CN102978054A Health-preserving red wine for female
03/20/2013CN102977218A Method for extracting polysaccharide from buckwheat brans
03/20/2013CN102977212A Compositions comprising anti-IGF-1r antibodies and methods for their production
03/20/2013CN102977205A Novel osteoprotegerin variant proteins
03/20/2013CN102977186A Glycine-L-cysteine-homotaurine tripeptide and application thereof
03/20/2013CN102977178A Triterpenoid saponin compound, extraction method of the triterpenoid saponin compound, and use of the triterpenoid saponin compound in treatment on myocardial ischemia/reperfusion injuries
03/20/2013CN102977177A Triterpenoid saponin class anti-myocardial ischemia chemical compound extracted from clematis tangutica
03/20/2013CN102977085A 2-aryl-benzo[d]oxazole and 2-aryl-benzo[d]thiazole derivatives, and preparation methods and application thereof
03/20/2013CN102977068A Nitric oxide donor type isochromanone derivatives, preparation methods and uses thereof
03/20/2013CN102977064A 4-chromone and 4-chromanone compounds and medical application thereof
03/20/2013CN102977048A Substituted cyclopentanes having prostaglandin activity
03/20/2013CN102977020A Aconitine alkaloids and preparation method thereof, and pharmaceutical composition using compounds as cardiotonic and anti-heart-failure active component and application thereof
03/20/2013CN102977016A Nitrogen-containing heteroaryl compounds and their use in increasing endogeneous erythropoietin
1 ... 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 ... 1595